-
1
-
-
79952232216
-
Global cancer statistics
-
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
-
(2011)
CA Cancer J Clin
, vol.61
, pp. 69-90
-
-
Jemal, A.1
Bray, F.2
Center, M.M.3
Ferlay, J.4
Ward, E.5
Forman, D.6
-
2
-
-
84963852548
-
Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2013
-
Oh CM, Won YJ, Jung KW, Kong HJ, Cho H, Lee JK, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2013. Cancer Res Treat. 2016;48:436-50.
-
(2016)
Cancer Res Treat
, vol.48
, pp. 436-450
-
-
Oh, C.M.1
Won, Y.J.2
Jung, K.W.3
Kong, H.J.4
Cho, H.5
Lee, J.K.6
-
3
-
-
33745822387
-
Esophageal cancer: a review and update
-
Layke JC, Lopez PP. Esophageal cancer: a review and update. Am Fam Physician. 2006;73:2187-94.
-
(2006)
Am Fam Physician
, vol.73
, pp. 2187-2194
-
-
Layke, J.C.1
Lopez, P.P.2
-
4
-
-
0030045032
-
Tumors of the esophagogastric junction: long-term survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy or inaccuracy of pTNM classification
-
Steup WH, De Leyn P, Deneffe G, Van Raemdonck D, Coosemans W, Lerut T. Tumors of the esophagogastric junction: long-term survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy or inaccuracy of pTNM classification. J Thorac Cardiovasc Surg. 1996;111: 85-94.
-
(1996)
J Thorac Cardiovasc Surg
, vol.111
, pp. 85-94
-
-
Steup, W.H.1
De Leyn, P.2
Deneffe, G.3
Van Raemdonck, D.4
Coosemans, W.5
Lerut, T.6
-
5
-
-
79959572435
-
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis
-
Sjoquist KM, Burmeister BH, Smithers BM, Zalcberg JR, Simes RJ, Barbour A, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol. 2011;12:681-92.
-
(2011)
Lancet Oncol
, vol.12
, pp. 681-692
-
-
Sjoquist, K.M.1
Burmeister, B.H.2
Smithers, B.M.3
Zalcberg, J.R.4
Simes, R.J.5
Barbour, A.6
-
6
-
-
84861679981
-
Preoperative chemoradiotherapy for esophageal or junctional cancer
-
van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074-84.
-
(2012)
N Engl J Med
, vol.366
, pp. 2074-2084
-
-
van Hagen, P.1
Hulshof, M.C.2
van Lanschot, J.J.3
Steyerberg, E.W.4
van Berge Henegouwen, M.I.5
Wijnhoven, B.P.6
-
7
-
-
84940595393
-
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
-
Shapiro J, van Lanschot JJ, Hulshof MC, van Hagen P, van Berge Henegouwen MI, Wijnhoven BP, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2015;16: 1090-8.
-
(2015)
Lancet Oncol
, vol.16
, pp. 1090-1098
-
-
Shapiro, J.1
van Lanschot, J.J.2
Hulshof, M.C.3
van Hagen, P.4
van Berge Henegouwen, M.I.5
Wijnhoven, B.P.6
-
8
-
-
76949094319
-
Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer
-
Allum WH, Stenning SP, Bancewicz J, Clark PI, Langley RE. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol. 2009;27:5062-7.
-
(2009)
J Clin Oncol
, vol.27
, pp. 5062-5067
-
-
Allum, W.H.1
Stenning, S.P.2
Bancewicz, J.3
Clark, P.I.4
Langley, R.E.5
-
9
-
-
84865517055
-
Preoperative staging of clinically node-negative esophageal cancer by the combination of 18F-fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT)
-
Yano M, Motoori M, Tanaka K, Kishi K, Fujiwara Y, Shingai T, et al. Preoperative staging of clinically node-negative esophageal cancer by the combination of 18F-fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT). Esophagus. 2012;9:210-6.
-
(2012)
Esophagus
, vol.9
, pp. 210-216
-
-
Yano, M.1
Motoori, M.2
Tanaka, K.3
Kishi, K.4
Fujiwara, Y.5
Shingai, T.6
-
10
-
-
1542438628
-
Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study: JCOG-9204
-
Ando N, Iizuka T, Ide H, Ishida K, Shinoda M, Nishimaki T, et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study: JCOG-9204. J Clin Oncol. 2003;21:4592-6.
-
(2003)
J Clin Oncol
, vol.21
, pp. 4592-4596
-
-
Ando, N.1
Iizuka, T.2
Ide, H.3
Ishida, K.4
Shinoda, M.5
Nishimaki, T.6
-
11
-
-
0030789850
-
Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer
-
Bleiberg H, Conroy T, Paillot B, Lacave AJ, Blijham G, Jacob JH, et al. Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer. Eur J Cancer. 1997;33:1216-20.
-
(1997)
Eur J Cancer
, vol.33
, pp. 1216-1220
-
-
Bleiberg, H.1
Conroy, T.2
Paillot, B.3
Lacave, A.J.4
Blijham, G.5
Jacob, J.H.6
-
12
-
-
23844548398
-
Long-term administration of low-dose cisplatin plus 5-fluorouracil prolongs the postoperative survival of patients with esophageal cancer
-
Shiozaki A, Yamagishi H, Itoi H, Fujiwara H, Kikuchi S, Okamoto K, et al. Long-term administration of low-dose cisplatin plus 5-fluorouracil prolongs the postoperative survival of patients with esophageal cancer. Oncol Rep. 2005;13:667-72.
-
(2005)
Oncol Rep
, vol.13
, pp. 667-672
-
-
Shiozaki, A.1
Yamagishi, H.2
Itoi, H.3
Fujiwara, H.4
Kikuchi, S.5
Okamoto, K.6
-
13
-
-
84856684523
-
A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907)
-
Ando N, Kato H, Igaki H, Shinoda M, Ozawa S, Shimizu H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68-74.
-
(2012)
Ann Surg Oncol
, vol.19
, pp. 68-74
-
-
Ando, N.1
Kato, H.2
Igaki, H.3
Shinoda, M.4
Ozawa, S.5
Shimizu, H.6
-
14
-
-
84978726166
-
Survival after neoadjuvant and adjuvant treatments compared to surgery alone for resectable esophageal carcinoma: a network meta-analysis
-
Pasquali S, Yim G, Vohra RS, Mocellin S, Nyanhongo D, Marriott P, et al. Survival after neoadjuvant and adjuvant treatments compared to surgery alone for resectable esophageal carcinoma: a network meta-analysis. Ann Surg. 2017;265: 481-91.
-
(2017)
Ann Surg
, vol.265
, pp. 481-491
-
-
Pasquali, S.1
Yim, G.2
Vohra, R.S.3
Mocellin, S.4
Nyanhongo, D.5
Marriott, P.6
-
15
-
-
84896710018
-
Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial
-
Conroy T, Galais MP, Raoul JL, Bouche O, Gourgou-Bourgade S, Douillard JY, et al. Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial. Lancet Oncol. 2014;15:305-14.
-
(2014)
Lancet Oncol
, vol.15
, pp. 305-314
-
-
Conroy, T.1
Galais, M.P.2
Raoul, J.L.3
Bouche, O.4
Gourgou-Bourgade, S.5
Douillard, J.Y.6
-
16
-
-
23844457288
-
Phase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus
-
Mauer AM, Kraut EH, Krauss SA, Ansari RH, Kasza K, Szeto L, et al. Phase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus. Ann Oncol. 2005;16:1320-5.
-
(2005)
Ann Oncol
, vol.16
, pp. 1320-1325
-
-
Mauer, A.M.1
Kraut, E.H.2
Krauss, S.A.3
Ansari, R.H.4
Kasza, K.5
Szeto, L.6
-
17
-
-
84899956571
-
Survival benefits of postoperative chemoradiation for lymph node-positive esophageal squamous cell carcinoma
-
Hsu PK, Huang CS, Wang BY, Wu YC, Hsu WH. Survival benefits of postoperative chemoradiation for lymph node-positive esophageal squamous cell carcinoma. Ann Thorac Surg. 2014;97:1734-41.
-
(2014)
Ann Thorac Surg
, vol.97
, pp. 1734-1741
-
-
Hsu, P.K.1
Huang, C.S.2
Wang, B.Y.3
Wu, Y.C.4
Hsu, W.H.5
-
18
-
-
25144525612
-
Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma
-
Lee J, Lee KE, Im YH, Kang WK, Park K, Kim K, et al. Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma. Ann Thorac Surg. 2005;80:1170-5.
-
(2005)
Ann Thorac Surg
, vol.80
, pp. 1170-1175
-
-
Lee, J.1
Lee, K.E.2
Im, Y.H.3
Kang, W.K.4
Park, K.5
Kim, K.6
|